{"name":"Zarour, Hassane, MD","slug":"zarour-hassane-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fecal Microbiota Transplant with Pembrolizumab","genericName":"Fecal Microbiota Transplant with Pembrolizumab","slug":"fecal-microbiota-transplant-with-pembrolizumab","indication":"Melanoma","status":"phase_2"}]}],"pipeline":[{"name":"Fecal Microbiota Transplant with Pembrolizumab","genericName":"Fecal Microbiota Transplant with Pembrolizumab","slug":"fecal-microbiota-transplant-with-pembrolizumab","phase":"phase_2","mechanism":"Fecal microbiota transplant modulates the gut microbiome to stimulate an anti-tumor immune response through PD-1/PD-L1 pathway.","indications":["Melanoma","Non-small cell lung cancer","Head and neck squamous cell carcinoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOTUt0NmlOU256WDlSN2NFQ2stZDlZM0MzTUVOS18ybWUtbDNlcENibGhNMWlwampnTTJFSDlIMEFmcFNaZ0QydTlDZGJaWjkzV2ZlLUVzWjdHbW1tSjk2MnNTalpPSDZTZHhOZE9PZHNKb1R1eV9NRFZXcDBmY3dlclFaWi1qekVoLU0ySk84S3diNE1PeDFvM1Rwem5hTGdSMGZQRmNaWG1ZSkh1N3ptd2FrZUFSdw?oc=5","date":"2024-03-28","type":"pipeline","source":"ASCO Daily News","summary":"Microbiome-Targeted Therapies Can Improve Cancer Outcomes. What Oncologists Should Know About the Potential Impact of Probiotics on Therapy Response - ASCO Daily News","headline":"Microbiome-Targeted Therapies Can Improve Cancer Outcomes. What Oncologists Should Know About the Potential Impact of Pr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQZE9nU0RpWUFmUDhyVC0zRFcwWm1md0gxNVM0czdwUkVWTFVZOElhcjdkaWo3LW1KNHJKUUUxOEJDSkFhV2UybDF0RkpOMjZXX29KZ09HbmJ0LWltWDJyQjlocGZHd19NTmtoUHVDTzFTWWFsZWlJSjcxWFBUNFhoYmZuazJiRlhPTzg1dnNVc1NhM2JSN3IxWldnaVc4Q0tkdGotbnZ0ZVhBYS1TNmFzX3hpZERIR2l3TjMxS1htemh0OGN0UE1tX2w1WUFCRW9PVDFzYm9hQkRYUQ?oc=5","date":"2022-05-24","type":"pipeline","source":"The Chronicle-Journal","summary":"MaaT Pharma to Host First Virtual R&D Day on June 7th, 2022 - The Chronicle-Journal","headline":"MaaT Pharma to Host First Virtual R&D Day on June 7th, 2022 - The Chronicle","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}